We are live on ! Find out more
CCI

Columbus Circle Investors Portfolio holdings

AUM $2.28B
1-Year Est. Return 135.57%
This Fund
S&P 500
This Quarter Est. Return
+10.81%
1 Year Est. Return
+135.57%
3 Year Est. Return
+366.4%
5 Year Est. Return
+795.38%
10 Year Est. Return
AUM
$9.26B
AUM Growth
-$710M
Cap. Flow
-$1.43B
Cap. Flow %
-15.44%
Top 10 Hldgs %
25.12%
Holding
330
New
82
Increased
62
Reduced
127
Closed
59

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$138M
2
SBUX icon
Starbucks
SBUX
+$135M
3
TGT icon
Target
TGT
+$93.6M
4
MCD icon
McDonald's
MCD
+$89.1M
5
COF icon
Capital One
COF
+$86.5M

Sector Composition

Rank Sector Weight
1 Technology 25.13%
2 Healthcare 21.96%
3 Consumer Discretionary 13.97%
4 Industrials 9.19%
5 Consumer Staples 8.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INXN
251
DELISTED
Interxion Holding N.V.
INXN
$986K 0.01%
27,221
+10,487
+63% +$391K
AERI
252
PUT
DELISTED
Aerie Pharmaceuticals
AERI
$974K 0.01%
+25,800
New +$569K
AMSG
253
DELISTED
Amsurg Corp
AMSG
$929K 0.01%
13,853
-2,433
-15% -$170K
AIMT
254
DELISTED
Aimmune Therapeutics
AIMT
$918K 0.01%
+61,198
New +$826K
GHDX
255
DELISTED
Genomic Health, Inc.
GHDX
$914K 0.01%
31,607
-21,546
-41% -$600K
RPD icon
256
Rapid7
RPD
$773M
$906K 0.01%
+51,310
New +$802K
TXMD icon
257
TherapeuticsMD
TXMD
$24M
$896K 0.01%
2,632
+1,472
+127% +$538K
MB
258
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
$885K 0.01%
+45,040
New +$789K
RAD
259
DELISTED
Rite Aid Corporation
RAD
$883K 0.01%
+5,741
New +$857K
AMED
260
DELISTED
Amedisys
AMED
$821K 0.01%
17,309
-162
-0.9% -$8.08K
EMWP
261
DELISTED
Eros Media World PLC
EMWP
$747K 0.01%
+2,437
New +$835K
BRCD
262
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
$725K 0.01%
+78,500
New +$732K
MOH icon
263
Molina Healthcare
MOH
$10.3B
$675K 0.01%
+11,574
New +$638K
AVDL
264
DELISTED
Avadel Pharmaceuticals
AVDL
$615K 0.01%
49,571
-13,242
-21% -$173K
NSTG
265
DELISTED
NanoString Technologies, Inc.
NSTG
$596K 0.01%
+29,826
New +$473K
PTCT icon
266
PTC Therapeutics
PTCT
$6.12B
$557K 0.01%
+39,732
New +$323K
RGEN icon
267
Repligen
RGEN
$9.25B
$357K ﹤0.01%
+11,810
New +$356K
CSOD
268
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$325K ﹤0.01%
7,077
-15,196
-68% -$666K
TUBE
269
DELISTED
TubeMogul, Inc.
TUBE
$324K ﹤0.01%
+34,554
New +$349K
CLVS
270
DELISTED
Clovis Oncology, Inc.
CLVS
$228K ﹤0.01%
+6,337
New +$136K
MX icon
271
Magnachip Semiconductor
MX
$145M
$168K ﹤0.01%
+20,141
New +$146K
ACHC icon
272
Acadia Healthcare
ACHC
$2.94B
-16,300
Closed -$903K
ADBE icon
273
Adobe
ADBE
$105B
-18,090
Closed -$1.73M
CAG icon
274
Conagra Brands
CAG
$7.23B
-333,252
Closed -$12.4M
CATY icon
275
Cathay General Bancorp
CATY
$4.24B
-173,856
Closed -$4.9M

Similar funds

Columbus Circle Investors's Q3 2016 Portfolio in Review

As of Q3 2016, Columbus Circle Investors held 330 positions worth $9.26B, down 7.1% from $9.97B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Columbus Circle Investors withdrew a net $1.43B in Q3 2016, closing 59 positions and reducing 127 holdings. Its most notable exit was Gilead Sciences, an estimated $138M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Columbus Circle Investors opened a new position in Intel worth $71.5M.

  • Columbus Circle Investors's largest Q3 2016 buy was Intel: 1,894,211 shares worth $71.5M.
  • Columbus Circle Investors added most to Fidelity National Information Services in Q3 2016, an estimated $85.6M increase.
  • Columbus Circle Investors's biggest Q3 2016 reduction was Visa, cutting an estimated $79M.
  • Columbus Circle Investors fully exited Gilead Sciences in Q3 2016, selling an estimated $138M.
  • Columbus Circle Investors's ten largest holdings make up 25% of its $9.26B portfolio in Q3 2016.
  • Columbus Circle Investors opened 82 new positions and closed 59 in Q3 2016.
  • Columbus Circle Investors's portfolio value fell 7.1% quarter-over-quarter to $9.26B.

Based on Columbus Circle Investors's 13F filing for Q3 2016, filed 10 Nov 2016.